Kyoto University professor questions effectivity of CCP virus vaccine in preventing severe illness

On 15th October, according to the media report, till 27th September 2022, 80% of Japanese citizens have already taken 2 shots of CCP virus vaccine, however, this hasn’t ended the transmission of CCP virus. The following is an excerpt from a new book titled “The Nature of COVID-19 Vaccine Failure” by Mr. Takayuki Miyazawa, Associate Professor in the Field of Virus Evolution, Institute of Medical Biology, Kyoto University, and the book stated that Mr. Takayuki Miyazawa and Mr. Torutoridamari had doubts about the effectiveness of vaccines in preventing severe disease.

Mr. Torutoridamari had interviewed several virus and vaccine researchers before the introduction of the CCP virus vaccine, and they all believed that even if a vaccine was introduced, it would be difficult to prevent infection. But once the CCP virus vaccine was launched, people were delusional, and experts no longer disagreed. Mr. Takayuki Miyazawa does not think the CCP virus vaccine is effective in preventing serious illness. Because even in cases of pneumonia caused by coronavirus infection, antibodies in the blood are ineffective. In fact, the new coronavirus is almost non-existent in the blood. If the new coronavirus can be transmitted in blood, then the test method should not use the nasal test, but directly take a blood sample or do a PCR test. Raising antibodies in the blood doesn’t make much sense if there is no virus in the blood. Vaccine experts have known from the beginning that the CCP virus vaccine is not very effective in preventing infection because it is difficult to raise IgA (antibodies that appear in the mucous membranes of the eyes, nose, upper respiratory tract, intestines, etc.).